Success Metrics

Active Trials
3(100%)

Phase Distribution

Ph phase_2
2
67%
Ph not_applicable
1
33%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
2(66.7%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

3

all time

Status Distribution
Active(3)

Detailed Status

Recruiting3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
3
Success Rate
N/A
Most Advanced
Phase 2

Trials by Phase

Phase 22 (66.7%)
N/A1 (33.3%)

Trials by Status

recruiting3100%

Recent Activity

3 active trials
Showing 3 of 3
recruitingnot_applicable

Comparison of Microbiome Changes in Healthy Adults Following Ketone Ester Consumption

NCT06954675
recruitingphase_2

Exogenous Ketone Esters for Refractory Status Epileptics

NCT05674552
recruitingphase_2

Exogenous Ketone Esters for Drug Resistant Epilepsy

NCT05670847

Clinical Trials (3)

Showing 3 of 3 trials
NCT06954675Not Applicable

Comparison of Microbiome Changes in Healthy Adults Following Ketone Ester Consumption

Recruiting
NCT05674552Phase 2

Exogenous Ketone Esters for Refractory Status Epileptics

Recruiting
NCT05670847Phase 2

Exogenous Ketone Esters for Drug Resistant Epilepsy

Recruiting

All 3 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
3